Artikel
Nervus intermedius influences continuous facial nerve EMG-monitoring
Suche in Medline nach
Autoren
Veröffentlicht: | 13. Mai 2014 |
---|
Gliederung
Text
Objective: In vestibular schwannoma surgery, facial nerve function may be monitored by quantification of A-trains, a specific pathological pattern, using the parameter traintime. However, false positive results with high traintime and comparatively mild postoperative functional deficits have been observed. This study tries to link this phenomenon to the presence of an anatomically and/or electrophysiologically identifiable Nervus intermedius (NI).
Method: In a consecutive group of 87 patients undergoing vestibular schwannoma surgery, the operative videotapes and electrophysiological data from intermittent electrical stimulation were analysed with respect to the presence/absence of a “split facial nerve”, in which the smaller portion represents the NI. The influence of this dichotomic criterion on facial nerve monitoring results, namely the correlation between traintime and postoperative facial nerve function, was scrutinized.
Results: In the majority of patients (48 out of 87), the NI was identified successfully. In those cases in which it reacted to electrical stimulation, EMG-responses were found mainly in the orbicular oris and the paranasal muscles. Statistical correlation between traintime and functional postoperative outcome was significantly better in the patient group without visible NI as compared to those patients in which the nerve was actually identified (Spearman's Rho 0.73 vs. 0.43). This inferior correlation resulted from additional pronounced A-train activity in EMG-channels covering the orbicular oris and paranasal muscles.
Conclusions: It appears that the NI contributes motor fibers to the facial muscles, targeting mainly the orbicular oris and paranasal muscles. Its presence as an identifiable structure may lead to pronounced manipulation, which in turn seems to interfere with facial nerve monitoring, producing A-train activity without significant clinical correlate.